Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 10, 2010, Pages 5019-5029

  Li, Xiaodong ^a,b   Wu, Kaijin ^a,b   Edman, Maria ^a   Schenke Layland, Katja ^b   MacVeigh Aloni, Michelle ^a   Janga, Srikanth Reddy ^a   Schulz, Barbara ^a   Hamm Alvarez, Sarah F ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN H; CATHEPSIN S; CD68 ANTIGEN; CATHEPSIN; CYTOKINE; MESSENGER RNA;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATHEPSIN GENE; CATHEPSIN H GENE; CATHEPSIN S GENE; CATHEPSIN Z GENE; CONTROLLED STUDY; CYTOKINE GENE; GENE; GENE EXPRESSION; IMMUNOFLUORESCENCE; INTERLEUKIN 1BETA GENE; INTERLEUKIN 6 GENE; LACRIMAL GLAND; LIPID STORAGE; LYSOSOME; MACROPHAGE; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SECRETORY VESICLE; TUMOR NECROSIS FACTOR GENE; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; DACRYOCYSTITIS; DISEASE MODEL; DNA MICROARRAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LACRIMAL APPARATUS; LACRIMAL FLUID; LEUKOCYTE; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, WESTERN; CATHEPSINS; CYTOKINES; DACRYOCYSTITIS; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; LACRIMAL APPARATUS; LEUKOCYTES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICROSCOPY, CONFOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TEARS;

EID: 77958126265     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4523     Document Type: Article

References (46)

1. Hunger RE, Carnaud C, Vogt I, Mueller C. Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice. J Clin Invest. 1998;101:1300-1309.
2. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu. 1980;29:1-13.
3. van Blokland SC, Versnel MA. Pathogenesis of Sjogren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy. Clin Immunol. 2002;103:111-124.
4. Wu K, Joffre C, Li X, et al. Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland. Exp Eye Res. 2009;89:319-332.
5. Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995;154:180-191.
6. Schenke-Layland K, Xie J, Magnusson M, et al. Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrixstructures in NOD mice which exhibit Sjögren's syndrome-like exocrinopathy. Exp Eye Res. 2010;90(2):223-237.
7. Ding C, MacVeigh M, Pidgeon M, et al. Unique ultrastructure of exorbital lacrimal glands in male NOD and BALB/c mice. Curr Eye Res. 2006;31:13-22.
8. Izumi M, Eguchi K, Nakamura H, Nagataki S, Nakamura T. Premature fat deposition in the salivary glands associated with Sjogren syndrome: MR and CT evidence. AJNR Am J Neuroradiol. 1997; 18:951-958.
9. Izumi M, Eguchi K, Uetani M, et al. MR features of the lacrimal gland in Sjogren's syndrome. AJR Am J Roentgenol. 1998;170: 1661-1666.
10. Taleb S, Lacasa D, Bastard JP, et al. Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis. FASEB J. 2005;19:1540-1542.
11. Alvarez B, Carbo N, Lopez-Soriano J, et al. Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue. Biochim Biophys Acta. 2002;1570:33-37.
12. Nielsen AR, Hojman P, Erikstrup C, et al. Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass. J Clin Endocrinol Metab. 2008;93:4486-4493.
13. Bouloumie A, Curat CA, Sengenes C, Lolmede K, Miranville A, Busse R. Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care. 2005;8:347-354.
14. Clement K, Langin D. Regulation of inflammation-related genes in human adipose tissue. J Intern Med. 2007;262:422-430.
15. Chang WW, Yeh CT, Wu CW, Chang JY. Lysosomal cysteine proteinase cathepsin S as a potential target for anti-cancer therapy. J Cancer Mol. 2007;3:5-14.
16. Vasiljeva O, Reinheckel T, Peters C, Turk D, Turk V, Turk B. Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Des. 2007;13:387-403.
17. Pender MP, Csurhes PA, Wolfe NP, et al. Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis. J Clin Neurosci. 2003;10:63-66.
18. Shamshiev A, Donda A, Carena I, Mori L, Kappos L, De Libero G. Self glycolipids as T-cell autoantigens. Eur J Immunol. 1999;29: 1667-1675.
19. Ilyas AA, Chen ZW, Cook SD. Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol. 2003;139:76-80.
20. Sadatipour BT, Greer JM, Pender MP. Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis. Ann Neurol. 1998;44:980-983.
21. Uhlig H, Dernick R. Monoclonal autoantibodies derived from multiple sclerosis patients and control persons and their reactivities with antigens of the central nervous system. Autoimmunity. 1989; 5:87-99.
22. Kanter JL, Narayana S, Ho PP, et al. Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med. 2006;12: 138-143.
23. Nakagawa TY, Brissette WH, Lira PD, et al. Impaired invariant chain degradation and antigen presentation and diminished collagen- induced arthritis in cathepsin S null mice. Immunity. 1999; 10:207-217.
24. Saegusa K, Ishimaru N, Yanagi K, et al. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J Clin Invest. 2002;110:361-369.
25. Schenke-Layland K, Xie J, Angelis E, et al. Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjogren's syndrome. Matrix Biol. 2008;27:53-66.
26. Fernandez PL, Farre X, Nadal A, et al. Expression of cathepsins B and S in the progression of prostate carcinoma. Int J Cancer. 2001;95:51-55.
27. Guha S, Padh H. Cathepsins: Fundamental effectors of endolysosomal proteolysis. Indian J Biochem Biophys. 2008;45:75-90.
28. Beers C, Burich A, Kleijmeer MJ, Griffith JM, Wong P, Rudensky AY. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo. J Immunol. 2005;174:1205-1212.
29. Taleb S, Cancello R, Poitou C, et al. Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women. J Clin Endocrinol Metab. 2006;91:1042-1047.
30. Ondr JK, Pham CT. Characterization of murine cathepsinWand its role in cell-mediated cytotoxicity. J Biol Chem. 2004;279:27525-27533.
31. Bosma GC, Fried M, Custer RP, Carroll A, Gibson DM, Bosma MJ. Evidence of functional lymphocytes in some (leaky) scid mice. J Exp Med. 1988;167:1016-1033.
32. Wilmarth PA, Riviere MA, Rustvold DL, Lauten JD, Madden TE, David LL. Two-dimensional liquid chromatography study of the human whole saliva proteome. J Proteome Res. 2004;3:1017-1023.
33. de Souza GA, Godoy LM, Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol. 2006;7:R72.
34. Dodt J, Reichwein J. Human cathepsin H: deletion of the minichain switches substrate specificity from aminopeptidase to endopeptidase. Biol Chem. 2003;384:1327-1332.
35. Kirschke H, Langner J, Wiederanders B, Ansorge S, Bohley P, Hanson H. Cathepsin H: an endoaminopeptidase from rat liver lysosomes. Acta Biol Med Ger. 1977;36:185-199.
36. Ritonja A, Popovic T, Kotnik M, Machleidt W, Turk V. Amino acid sequences of the human kidney cathepsins H and L. FEBS Lett. 1988;228:341-345.
37. Fain JN, Cheema PS, Bahouth SW, Lloyd Hiler M. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun. 2003;300:674-678.
38. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83:847-850.
39. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95: 2409-2415.
40. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87-91.
41. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145:2273-2282.
42. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-1808.
43. Zeyda M, Stulnig TM. Adipose tissue macrophages. Immunol Lett. 2007;112:61-67.
44. Brix K, Dunkhorst A, Mayer K, Jordans S. Cysteine cathepsins: cellular roadmap to different functions. Biochimie (Paris). 2008; 90:194-207.
45. Rose CM, Qian L, Hakim L, et al. Accumulation of catalytically active proteases in lacrimal gland acinar cell endosomes during chronic ex vivo muscarinic receptor stimulation. Scand J Immunol. 2005;61:36-50.
46. de Saint Jean M, Nakamura T, Wang Y, Trousdale MD, Schechter JE, Mircheff AK. Suppression of lymphocyte proliferation and regulation of dendritic cell phenotype by soluble mediators from rat lacrimal epithelial cells. Scand J Immunol. 2009;70:53-62.